BECN1 and Alzheimer disease: Expression of Beclin1 (p < 0.001; Figures 6C,D) and ATG14 (p < 0.01; Figures 6C,D) were markedly decreased in the AD group compared with that of the WT group, which were protected by DHA treatment.